BRCA1 gene mutations may not be key to prostate cancer initiation, as previously thought

image via Medical Xpress - medical research advances and health news

February 25, 2025, 1:56 PM

• •BRCA1 gene variants are not key to prostate cancer initiation, suggests a new study.
• •The findings could lead to a reassessment of current treatment with PARP inhibitor drugs in men with BRCA1 genetic variants.
• •The study also suggests that somatic CDK12 and somatic and germline BRCA2 should no longer be considered mutually exclusive.

BRCA1 gene mutations may not be key to the initiation of prostate cancer, suggests a new study. The findings could lead to a reassessment of current treatment with PARP inhibitor drugs.

Read original article